openPR Logo
Press release

Antithrombin Market is estimated to be US$ 849.87 million by 2030 with a CAGR of 4.3% during the forecast period 2030 With Top Most Key Players - Takeda Pharmaceuticals, Siemens AG, Axis-Shield Plc., Grifols, CSL Limited, Thermo Fisher Scientific, Octapha

10-21-2022 02:10 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Prophecy Market Insights

Antithrombin Market is estimated to be US$ 849.87 million by 2030

The protein which blocks thrombin is called as antithrombin. Antithrombin is the glycoprotein which is synthesized by the liver. Antithrombin inhibits the proteases due to belonging to the family of serpins. Antithrombin used to thin the blood slightly from clotting alot. Antithrombin is an endogenous anticoagulant. Antiplatelets are the drugs used for preventing the formation of blood clots. Aspirin is the common antiplatelet drug. Other antiplatelet drug includes prasugrel, clopidogrel and ticagrelor. The deficiency or low level of antithrombin causes abnormal blood clots which results in the blockage of blood flow and damage the organs. Antithrombin maintains the balance in the coagulation system. The adequate level of antithrombin is important to be present in the body to avoid the high risk of thrombophilias. Antithrombin is used in surgical procedures to prevent the blood clotting. Use of antithrombin concentrates are useful in antithrombin deficiency. Antithrombin has anti-aggregant and anti-inflammatory properties. Antithrombin in the plasma ranges from 80% to 120%. Antithrombin concentrates are prepared from human plasma. Thus, increased use of antithrombin has given rise in the market growth. Global Antithrombin Market size accounted for US$ 577.2 million in 2020 and is estimated to be US$ 849.87 million by 2030 and is anticipated to register a CAGR of 4.3%.

To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Antithrombin-Market-4929

The report "Global Antithrombin Market, By Type (Thrombolytic Drugs, Anticoagulant, Antiplatelet and Others), By Application (Therapeutics, Research & Development, Diagnostics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030"

Key Highlights:
• In 2021, (PubMed Central), adequate Antithrombin III level predicted the survival in severe pandemic of COVID-19 Pneumonia. Antithrombin III has become the most potent endogenous anticoagulant. Antithrombin III is thus required for the clinical efficacy of heparin.
• In 2022, (csl.com), CSL Limited announced the positive top line phase 3 results for Garadacimab which has become preventive treatment in patients with HAE (Hereditary Angioedema). Garadacimab has become the potentially transformative first-in-class therapy for the patients having HAE (Hereditary Angioedema).

Analyst View:
Antithrombin has become important as it prevents excess blood clotting. The use of antithrombin in surgical procedures is increased due to rise in chronic diseases like heart disease, kidney disease. During surgical procedure antithrombin is required to prevent forming of blood clots. Antithrombin deficiency causes risk of thrombophilias. However, increase in surgical procedures and rise in deficiency of antithrombin has driven rise in demand of antithrombin which will be able to boosts the growth of the market. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.

Click To Get Sample Report:-
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4929

Segments Covered in the Report:

Global Antithrombin Market, By Type:
• Thrombolytic Drugs
• Anticoagulant
• Antiplatelet
• Others
Global Antithrombin Market, By Application:
• Therapeutics
• Research & Development
• Diagnostics
• Others

Key Market Insights from the report:
Global Antithrombin Market size accounted for US$ 577.2 million in 2020 and is estimated to be US$ 849.87 million by 2030 and is anticipated to register a CAGR of 4.3%. The Global Antithrombin Market is segmented based on Type, Application and Region.
• Based on Type, Global Antithrombin Market is segmented into Thrombolytic Drugs, Anticoagulant, Antiplatelet and others.
• Based on Application, Global Antithrombin Market is segmented into Therapeutics, Research & Development, Diagnostics, and others.
• By Region, the Global Antithrombin Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Global Antithrombin Market:
The prominent players operating in the Global Antithrombin Market includes, Takeda Pharmaceuticals, Siemens AG, Axis-Shield Plc., Grifols, CSL Limited, Thermo Fisher Scientific, Octapharma AG, Lee Biosolutions Inc., Shire Plc., LFB USA, Scripps Laboratories Inc., Kedrion S.p.A., Novartis International AG, Bristol-Myers Squibb Company, Merck & Co., and others.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Other Related Reports:-

https://www.openpr.com/news/2248689/global-nitrous-oxide-market-keyplayers-matheson-tri-gas

https://www.openpr.com/news/2248688/global-construction-chemicals-market-rpm-international-sika

https://www.openpr.com/news/2247943/global-brand-drugs-market-pfizer-inc-roche-inc-sanofi

964 E. BadilloStreet #2042 Covina, CA 91724
US toll free: +1 860 531 2701
Rest of world: + 91 7775049802
Email:sales@prophecymarketinsights.com
Website:www.prophecymarketinsights.com

About Us:Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antithrombin Market is estimated to be US$ 849.87 million by 2030 with a CAGR of 4.3% during the forecast period 2030 With Top Most Key Players - Takeda Pharmaceuticals, Siemens AG, Axis-Shield Plc., Grifols, CSL Limited, Thermo Fisher Scientific, Octapha here

News-ID: 2775502 • Views:

More Releases from Prophecy Market Insights

Floating Power Plant Market: Powering the Future of Renewable Energy
Floating Power Plant Market: Powering the Future of Renewable Energy
Introduction The Floating Power Plant Market is rapidly emerging as a transformative solution to the world's growing energy needs. With increasing global demand for sustainable, flexible, and decentralized power generation, floating power plants (FPPs) are gaining traction as they can be deployed in offshore waters, lakes, and reservoirs. These plants integrate renewable energy sources like wind, solar, and wave energy with conventional power systems, providing a reliable energy mix. Driven by rising
AI-Enabled Kitchen Appliances Market: Driving the Future of Smart Living
AI-Enabled Kitchen Appliances Market: Driving the Future of Smart Living
Introduction The AI-Enabled Kitchen Appliances Market is experiencing unprecedented growth as artificial intelligence becomes a core component of modern homes. With the rise of smart homes, connected devices, and consumer demand for convenience, AI-driven appliances are redefining the way people cook, store, and manage food. From refrigerators that track expiry dates to ovens that auto-adjust based on recipes, these innovations are revolutionizing kitchens worldwide. Industry forecasts suggest that the market will witness
Europe Dominates 2024 Residential Energy Storage Market, Poised for 9.5% CAGR Growth
Europe Dominates 2024 Residential Energy Storage Market, Poised for 9.5% CAGR Gr …
The Residential Energy Storage Market is witnessing strong momentum, expected to grow from USD 2.8 billion in 2024 to USD 6.8 billion by 2035, expanding at a robust CAGR of 9.5% (2025-2030). Europe led the global market in 2024 owing to its significant investments in renewable energy integration, supportive government policies, and growing demand for energy independence. Unlock the full potential of the Residential Energy Storage Market with in-depth insights, market
Commercial Refrigeration Equipment - A Cornerstone for Food Quality and Sustainability, Market to Reach USD 71.8 Billion by 2035
Commercial Refrigeration Equipment - A Cornerstone for Food Quality and Sustaina …
The Commercial Refrigeration Equipment Market is set for significant expansion, growing from USD 43.0 billion in 2024 to USD 71.8 billion by 2035, progressing at a CAGR of 5.3% (2025-2035). The Asia Pacific region held the largest share in 2024 and continues to dominate due to rising demand for advanced refrigeration solutions across retail, foodservice, and cold-chain logistics. Gain in-depth insights into the Commercial Refrigeration Equipment Market, including regional forecasts, emerging

All 5 Releases


More Releases for Antithrombin

Antithrombin Market - From Safety to Success: Antithrombin Solutions for Effecti …
Newark, New Castle, USA: The "Antithrombin Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Antithrombin Market: https://www.growthplusreports.com/report/antithrombin-market/7760 This latest report researches the industry structure, sales, revenue, price and
Antithrombin Market Size, Share & Growth Report 2030
The global Antithrombin market accounted for USD 543.0 Million in 2020 and is expected to reach USD 820.8 Million by 2028, growing at a CAGR of 5.3% from 2021 to 2028. Antithrombin is a protein present in the blood stream, which functions as a naturally occurring mild blood thinner. Antithrombin helps to control too much clotting. A person with low antithrombin levels has more tendency to
Antithrombin Market Report Up to 2031
Visiongain has published a new report on Antithrombin Market Report to 2031. Market is segmented by source (Human, Goat milk, others), By Application (Therapeutics, Research, Diagnostic, Others), By Type (Anticoagulants, Antiplatele, Thrombolytic Drugs). Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Antithrombin Companies. PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/antithrombin-market/#download_sampe_div The study covers detailed and insightful chapters
Antithrombin Market Analysis 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI
Antithrombin Market - Size, Share, Outlook, 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI
Antithrombin Market analysis 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI